Walleye Capital LLC Heron Therapeutics, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $425,758 - $883,685	-189,226 Reduced 18.28%	845,856 $2.11 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $235,660 - $475,749	88,594 Added 9.36%	1,035,082 $4.37 Million
Q2 2022 Aug 08, 2022	BUY	$2.3 - $6.29 $1.94 Million - $5.3 Million	843,014 Added 814.71%	946,488 $2.64 Million
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $252,654 - $542,415	54,569 Added 111.58%	103,474 $592,000
Q4 2021 Mar 03, 2022	BUY	$8.35 - $12.6 $408,356 - $616,203	48,905 New	48,905 $446,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.